Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial — Matthew R. Smith (2022) | RDL Network
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Matthew R. Smith, Shahneen Sandhu, Daniel J. George, Kim Nguyen, Fred Saad, Antoine Thiery-Vuillemin, O. Ståhl, David Olmos, Daniel C. Danila, Rustem Gafanov, Elena Castro, Helen Moon, Anthony M. Joshua, Gary Mason, Byron M. Espina, Yan Liu, Angela Lopez‐Gitlitz, Peter Francis, Katherine B. Bevans, Karim Fizazi
Joaquı́n Mateo, Núria Porta, Diletta Bianchini, Ursula McGovern, Tony Elliott, Robert J. Jones, Isabel Syndikus, Christy Ralph, Suneil Jain, Mohini Varughese, Omi Parikh, Simon J. Crabb, Angus Robinson, Duncan B. McLaren, Alison Birtle, Jacob Tanguay, Susana Miranda, Ines Figueiredo, George Seed, Cláudia Bertan, Penny Flohr, Berni Ebbs, ,
Matthew R. Smith, Shahneen Sandhu, William Kevin Kelly, Howard I. Scher, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, Kim N., Jason M. Summa, Nishi Kothari, Xin Zhao, Byron M. Espina, Deborah Ricci, Jason S. Simon, NamPhuong Tran, Karim Fizazi
Matthew R. Smith, Karim Fizazi, Shahneen Sandhu, William Kevin Kelly, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, Kim N., Fred Saad, Jason M. Summa, Jamie Freedman, Gary Mason, Byron M. Espina, Eugene Zhu, Deborah Ricci, Linda A. Snyder, Jason S. Simon, Shinta Cheng, Howard I. Scher
Matthew R. Smith, Shahneen Sandhu, William Kevin Kelly, Howard I. Scher, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, K.N. Chi, Fred Saad, Jason M. Summa, John Freedman, Gary Mason, E Zhu, Deborah Ricci, Jason S. Simon, Shinta Cheng, Karim Fizazi
Discussion(0)
No comments yet. Be the first to comment.